Back to Vet Dispatch

Feline

Buspirone for Cats: Urine Spraying, Anxiety, and Off-Label Use in Feline Behavioral Medicine

Jul 12, 2026 6 min read

Bottom line

Buspirone is an azapirone anxiolytic used entirely off-label in cats, and its best-supported feline indication is urine spraying/marking — with a marked advantage in multi-cat, socially stressed households [1]. It acts as a serotonin 5-HT1A partial agonist (with partial dopamine D2 activity), delivering anxiolysis without the sedation, ataxia, or physical dependence of benzodiazepines [2][3]. Onset is slow — roughly 1–4 weeks — so it is a maintenance drug for generalized, social, and fear-based anxiety, NOT a rescue for acute situational anxiety [3]. Use it as an adjunct to environmental and behavioral management, typically as a second-line or add-on option to the better-evidenced SSRIs and TCAs.

From reading to clinical reasoning

Pressure-test the decisions behind this article

Open Clinical Desk with the public topic prefilled. Add patient context only after you are inside the secure vet workspace.

buspirone for cats

Patient details stay inside the authenticated workspace.

Drug facts

  • Class: azapirone anxiolytic — chemically and mechanistically distinct from the benzodiazepines [3].
  • Mechanism: partial agonist at pre- and postsynaptic serotonin 5-HT1A receptors with partial dopamine D2 receptor agonism [2][3]. It is anxioselective: minimal sedation and none of the anticonvulsant or muscle-relaxant activity of benzodiazepines. It does not produce physical dependence, even after months of continuous treatment [2].
  • Formulations: human generic oral tablets (originally marketed as BuSpar); there is no veterinary-labeled buspirone product, so every feline use is extra-label [4]. Oral bioavailability is good, but transdermal absorption in cats is poor — compounded transdermal gels are unreliable and should be avoided [2].
  • Regulatory status: no FDA veterinary approval and no labeled feline indication; prescribing rests on the veterinarian's extra-label clinical judgment [4].

Dosing in cats (off-label)

All feline dosing is extrapolated from small studies, formularies, and clinical experience — there is no label dose, so titrate to the individual patient.

  • A commonly cited range is 0.5–1 mg/kg PO q12–24h, up to about 7.5 mg/cat q12h [2].
  • Plumb's lists roughly 2.5–5 mg/cat PO q12h for anxiety and 2.5–7.5 mg/cat PO q12h for urine marking/spraying [4].
  • Dose twice daily. Buspirone has a short half-life and must be given on a fixed daily schedule, not on an as-needed basis [2].
  • Titrate and give it time. Clinical response typically takes 1–4 weeks (about 7–30 days) [3], with some sources citing 10–14 days [2]. Do not conclude failure before several weeks at an adequate twice-daily dose.

Efficacy evidence

The anchoring feline study is Hart, Eckstein, Powell, and Dodman (1993, JAVMA), an open trial of buspirone for urine spraying and inappropriate urination in cats [1]:

  • Buspirone produced a favorable response (>75% reduction in spraying) in 55% of treated cats [1].
  • Cats from multi-cat households responded significantly better than single-cat cats (P < 0.001) — fitting its role in social and territorial stress [1].
  • There was no sex difference in effectiveness between male and female cats [1].
  • Among cats with inappropriate urination (rather than spraying), 56% returned to normal litter box use [1].
  • Relapse after discontinuation was far lower than with diazepam: when buspirone was withdrawn after two months, only about half of responders resumed marking, versus over 90% of cats after diazepam withdrawal (P < 0.001) [1].

Interpret this honestly. As of 2026, the feline evidence base for buspirone is older and limited — much of it rests on this single trial and on extrapolation from human pharmacology — and buspirone has generally shown no greater control of anxiety-related behaviors than the benzodiazepines [3]. Its real edge is the favorable relapse and safety profile, not superior raw efficacy [1][2].

Adverse effects

Buspirone is generally very well tolerated and non-sedating [3].

  • Adverse effects are infrequent; mild gastrointestinal signs are the most likely, and sedation is only occasionally reported despite the anxioselective profile [2].
  • Some cats show increased affection or friendliness on treatment.
  • A clinically important behavioral caveat: because buspirone reduces fear and increases confidence, a previously timid or "victim" cat may become bolder and turn to confront the aggressor in a multi-cat conflict, shifting the household's social dynamics [2][5]. Anxiolytics can disinhibit fearful cats, and that new confidence can escalate into aggression — so direct buspirone at the fearful/target cat and use it cautiously wherever overt aggression already exists [5].

Contraindications and drug interactions

  • Hepatic or renal impairment: buspirone is hepatically metabolized and renally cleared; use cautiously and consider a lower dose in cats with liver or kidney disease [4].
  • MAO inhibitors — avoid: combining buspirone with an MAOI, including selegiline (L-deprenyl) and the topical acaricide amitraz, risks serotonin syndrome [2].
  • Other serotonergic drugs: effects are additive with SSRIs, TCAs, tramadol, and similar agents — combine deliberately and monitor for serotonin syndrome [4].
  • CYP3A4 inhibitors raise buspirone levels: buspirone is a CYP3A4 substrate, so azole antifungals (e.g., ketoconazole, itraconazole), macrolides (e.g., erythromycin, clarithromycin), and — in humans — grapefruit can substantially increase exposure; anticipate an exaggerated effect and reduce the dose accordingly [4].
  • Additive CNS depression is possible with other centrally acting agents [4].

Where buspirone sits versus alternatives

Versus benzodiazepines (e.g., diazepam): buspirone avoids benzodiazepine sedation, ataxia, and behavioral disinhibition, and it causes no dependence [3]. Critically, it sidesteps the rare but frequently fatal idiosyncratic hepatic necrosis reported with oral diazepam in cats — a landmark case series described fulminant hepatic failure after repeated oral diazepam, with most affected cats dying [6]. The trade-off is buspirone's slower onset — weeks, versus the near-immediate effect of a benzodiazepine [3].

Versus SSRIs and TCAs: for feline urine marking, the SSRI fluoxetine and the TCA clomipramine generally carry stronger, broader evidence and are common first-line maintenance choices; buspirone is frequently a second-line or adjunct agent and can be used specifically to enhance the anxiolytic effect of an SSRI or TCA [3].

Versus situational agents: buspirone's slow onset makes it unsuitable for acute, event-based anxiety such as veterinary visits or travel — for those, reach for a situational protocol such as gabapentin or trazodone instead [3].

Frequently Asked Questions

What is the buspirone dose for cats? There is no label dose — use is off-label. Commonly cited regimens are 0.5–1 mg/kg PO q12–24h, up to about 7.5 mg/cat q12h [2], while Plumb's lists roughly 2.5–5 mg/cat q12h for anxiety and 2.5–7.5 mg/cat q12h for urine marking [4]. Give it twice daily on a fixed schedule and titrate to effect [3].

How long does buspirone take to work in cats? Roughly 1–4 weeks (about 7–30 days) [3], with some sources citing 10–14 days [2]. It is a maintenance drug given daily, not a fast-acting situational option, so do not judge it a failure before several weeks at an adequate dose [3].

Buspirone vs fluoxetine for cat spraying — which is better? Fluoxetine, an SSRI, generally has stronger, broader evidence for feline urine marking and is a common first-line maintenance choice; buspirone is usually second-line or an adjunct, and can be used to enhance an SSRI's anxiolytic effect [3]. Buspirone's documented advantage is a much lower relapse rate after discontinuation than diazepam, plus a clean, non-sedating safety profile [1].

Is buspirone safe long term in cats? It is generally well tolerated for chronic use and, unlike benzodiazepines, does not cause dependence even after months of treatment [2]. Adverse effects are infrequent, with mild GI signs most common [2]. Use caution and consider dose reduction in cats with hepatic or renal impairment [4].

Can buspirone be combined with an SSRI? Yes, and it is done deliberately — buspirone is used to augment SSRIs and TCAs [3]. Because both are serotonergic, combine at conservative doses and monitor for serotonin syndrome [4]. Avoid concurrent MAOIs, including selegiline and topical amitraz [2].

Can buspirone be used for vet visits or travel? No. Its onset is 1–4 weeks, so it does nothing for acute, event-based anxiety [3]. Use a situational protocol such as gabapentin or trazodone for previsit or travel anxiety instead.

Why choose buspirone over diazepam in cats? Buspirone avoids benzodiazepine sedation, ataxia, disinhibition, and dependence [3], and it sidesteps the rare but frequently fatal idiosyncratic hepatic necrosis reported with oral diazepam in cats [6]. It also showed a far lower relapse rate after discontinuation than diazepam — about half versus over 90% [1]. The trade-off is a slower onset [3].

Does buspirone cause sedation in cats? It is anxioselective and essentially non-sedating [3], which is a key advantage over benzodiazepines. Sedation is occasionally reported, but adverse effects overall are infrequent, with mild GI signs the most likely [2].

References

  1. Hart BL, Eckstein RA, Powell KL, Dodman NH. Effectiveness of buspirone on urine spraying and inappropriate urination in cats. J Am Vet Med Assoc. 1993;203(2):254-258. (1993)
  2. Denenberg S, Bräm Dubé M. Tools for managing feline problem behaviours: Psychoactive medications. J Feline Med Surg. 2018;20(11):1034-1045. (2018)
  3. Merck Veterinary Manual. Psychotropic Agents for Treatment of Animals (Systemic Pharmacotherapeutics of the Nervous System). (2022)
  4. Plumb DC. Plumb's Veterinary Drug Handbook, 10th ed. — Buspirone HCl. Wiley-Blackwell. (2023)
  5. Merck Veterinary Manual. Behavior Problems of Cats. (2022)
  6. Center SA, Elston TH, Rowland PH, et al. Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. J Am Vet Med Assoc. 1996;209(3):618-625. (1996)

More clinical updates

CanineJul 11, 2026

Fluoxetine (Reconcile) for Canine Behavior Disorders

Clinical reference on fluoxetine (Reconcile/Prozac) for dogs: FDA-approved separation-anxiety indication, 1-2 mg/kg dosing, 4-6 week onset, adverse effects, and the MAOI/amitraz and serotonin-syndrome interactions every prescriber must screen for.

Read →
Dogs & CatsJul 12, 2026

Clomipramine (Clomicalm) for Dogs and Cats: Behavioral Dosing, Efficacy, and Safety

Clomipramine is a tricyclic antidepressant FDA-approved (Clomicalm) as an adjunct to behavior modification for canine separation anxiety, and used off-label for feline urine marking and canine/feline compulsive disorders. This hub covers species-specific dosing, the registration and compulsive-disorder RCTs, adverse effects, MAOI/serotonergic interactions, and where it sits versus fluoxetine, trazodone, and buspirone.

Read →
FelineJun 6, 2026

Gabapentin for Pre-Visit Feline Anxiety: Evidence and Clinical Use

The evergreen clinical reference on gabapentin in cats: randomized and systematic-review evidence for pre-visit anxiolysis, the ~40% ataxia rate and 8-hour resolution window, cardiovascular safety, the pregabalin comparison, and the emerging atopic-dermatitis adjunct signal.

Read →
CanineJul 11, 2026

Trazodone for Dogs: Situational Anxiety and Post-Op Confinement Dosing

A clinical reference for prescribing trazodone in dogs: SARI mechanism, off-label status, situational and post-operative confinement dosing, onset, adverse effects, and serotonin syndrome risk with concurrent SSRIs and MAOIs.

Read →